Virtus LifeSci Biotech Products ETF Rating $60.26 +0.34 (+0.57%) (As of 12/20/2024 04:32 PM ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.80Holdings in BBP have an aggregate rating of Moderate Buy based on 611 analyst ratings issued in the past year covering 50 companies (88.0% of the portfolio).BBP Aggregate Price Target$60.26High Prediction$60.26Average Prediction$60.26Low Prediction$60.26Holdings in BBP have an aggregate price target of $60.26 and a range of $60.26 to $60.26 covering 50 companies (88.0% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.86%TVTXTravere Therapeutics$17.18-1.3%2.7656 of 5 stars2.92$23.67 37.8%12Positive NewsHigh Trading Volume2.99%TGTXTG Therapeutics$32.20+4.0%4.3111 of 5 stars2.83$40.67 26.3%6Analyst DowngradePositive News2.61%ADMAADMA Biologics$17.40-2.8%3.775 of 5 stars3.25$21.25 22.1%4Positive NewsGap Down2.47%MIRMMirum Pharmaceuticals$41.51+0.9%4.0875 of 5 stars3.09$57.10 37.6%11Positive NewsHigh Trading Volume2.43%AUPHAurinia Pharmaceuticals$9.03-0.1%2.3269 of 5 stars2.75$10.00 10.7%42.31%EXELExelixis$33.29-1.2%4.5006 of 5 stars2.50$32.44 -2.6%18Analyst DowngradeAnalyst RevisionHigh Trading Volume2.26%ALNYAlnylam Pharmaceuticals$245.44+2.8%4.4119 of 5 stars2.71$298.09 21.5%24Analyst Upgrade2.17%TARSTarsus Pharmaceuticals$52.91+1.8%0.3248 of 5 stars3.00$54.20 2.4%7Gap Down2.15%LGNDLigand Pharmaceuticals$114.64+0.6%4.98 of 5 stars3.00$147.00 28.2%6Analyst RevisionHigh Trading Volume2.12%ZLABZai Lab$26.72+1.9%1.7088 of 5 stars3.00$55.00 105.8%32.11%GILDGilead Sciences$92.57+1.6%4.4784 of 5 stars2.67$96.43 4.2%27Insider TradeHigh Trading Volume2.01%PTCTPTC Therapeutics$46.24+2.2%3.6564 of 5 stars2.47$54.08 16.9%15Analyst Downgrade1.96%RYTMRhythm Pharmaceuticals$56.12+1.2%4.1095 of 5 stars2.90$65.80 17.2%10Analyst ForecastNews CoveragePositive NewsHigh Trading Volume1.95%AXSMAxsome Therapeutics$90.73+1.1%4.7641 of 5 stars3.00$125.93 38.8%14Positive News1.84%UTHRUnited Therapeutics$359.58-0.2%4.7048 of 5 stars2.73$370.86 3.1%15Analyst DowngradeInsider TradePositive NewsHigh Trading Volume1.80%AGIOAgios Pharmaceuticals$35.42-1.1%4.2892 of 5 stars2.50$56.33 59.0%8Analyst ForecastHigh Trading Volume1.80%ITCIIntra-Cellular Therapies$83.45-0.8%4.0477 of 5 stars2.85$97.23 16.5%131.77%BGNEBeiGene$176.50+1.0%2.6117 of 5 stars2.75$253.69 43.7%81.74%BNTXBioNTech$113.08+1.6%2.0872 of 5 stars2.82$140.76 24.5%171.69%BCRXBioCryst Pharmaceuticals$7.57+2.4%3.713 of 5 stars2.80$15.60 106.1%5News CoveragePositive News1.69%HRMYHarmony Biosciences$34.28+1.2%4.7827 of 5 stars2.60$49.80 45.3%10Analyst ForecastAnalyst RevisionHigh Trading Volume1.68%INSMInsmed$70.44+1.5%2.9718 of 5 stars3.00$83.67 18.8%16Insider TradeHigh Trading Volume1.67%INCYIncyte$68.84+2.7%4.7061 of 5 stars2.35$76.29 10.8%20Analyst ForecastHigh Trading Volume1.66%KNSAKiniksa Pharmaceuticals$20.59+0.5%2.5277 of 5 stars3.00$36.60 77.8%5Positive News1.65%ROIVRoivant Sciences$11.57+0.6%2.85 of 5 stars2.88$17.93 55.0%8Insider TradeHigh Trading Volume1.64%MDGLMadrigal Pharmaceuticals$308.44+5.1%4.2319 of 5 stars2.69$347.33 12.6%13Positive News1.58%RAREUltragenyx Pharmaceutical$44.22+1.7%4.4414 of 5 stars2.92$88.46 100.0%13Analyst ForecastNews CoveragePositive NewsHigh Trading Volume1.57%TBPHTheravance Biopharma$9.59-1.4%2.1626 of 5 stars2.40$13.75 43.4%51.57%ACADACADIA Pharmaceuticals$16.87+0.8%3.6975 of 5 stars2.63$25.60 51.7%16High Trading Volume1.55%DVAXDynavax Technologies$12.72-0.3%4.6464 of 5 stars2.67$22.00 73.0%3News CoveragePositive News1.54%IOVAIovance Biotherapeutics$7.38+2.2%4.0089 of 5 stars2.89$22.33 202.6%91.53%DAWNDay One Biopharmaceuticals$12.79+2.6%1.6159 of 5 stars3.00$35.71 179.2%9High Trading Volume1.53%SWTXSpringWorks Therapeutics$35.59+2.3%2.0068 of 5 stars3.00$69.50 95.3%61.52%ESPREsperion Therapeutics$2.19+0.9%3.908 of 5 stars2.40$7.30 233.3%5Analyst ForecastAnalyst RevisionNews Coverage1.52%KRYSKrystal Biotech$164.83+2.5%4.5154 of 5 stars3.00$206.67 25.4%8Analyst ForecastHigh Trading Volume1.49%ASNDAscendis Pharma A/S$136.38-1.0%3.1312 of 5 stars2.92$191.77 40.6%131.46%SRPTSarepta Therapeutics$118.97-0.4%4.8572 of 5 stars2.91$178.71 50.2%22Analyst ForecastPositive News1.42%LEGNLegend Biotech$34.08+0.2%1.5471 of 5 stars3.00$81.54 139.3%131.40%HALOHalozyme Therapeutics$46.96-0.8%4.9904 of 5 stars2.60$61.11 30.1%10Analyst ForecastPositive NewsHigh Trading Volume1.40%YMABY-mAbs Therapeutics$8.28-3.4%2.2437 of 5 stars3.00$20.89 152.3%10High Trading Volume1.39%VRTXVertex Pharmaceuticals$397.27+0.2%4.7433 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.34%FOLDAmicus Therapeutics$9.80+0.7%4.3193 of 5 stars2.78$16.88 72.2%9Analyst Downgrade1.33%AMGNAmgen$263.38+0.8%4.4622 of 5 stars2.40$319.67 21.4%25Analyst DowngradeGap UpHigh Trading Volume1.32%NBIXNeurocrine Biosciences$135.42+0.3%4.8286 of 5 stars2.83$166.00 22.6%23Analyst ForecastInsider TradePositive NewsHigh Trading Volume1.31%BBIOBridgeBio Pharma$26.49+1.1%4.6961 of 5 stars2.86$47.69 80.0%14High Trading Volume1.31%BPMCBlueprint Medicines$90.14+1.4%2.5681 of 5 stars2.65$123.33 36.8%20Insider Trade1.25%IONSIonis Pharmaceuticals$35.63+0.1%4.417 of 5 stars2.68$60.65 70.2%19Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume1.22%ARDXArdelyx$4.82+2.8%3.6907 of 5 stars2.88$10.42 116.1%81.21%CRSPCRISPR Therapeutics$40.72+0.8%2.5514 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume1.21%IBRXImmunityBio$2.62-1.9%2.1322 of 5 stars3.00$17.38 563.2%3Analyst Forecast This page (NYSEARCA:BBP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBP Stock Alerts